Skip to main content
XLAB
NASDAQ Technology

Exascale Labs Completes $500M SPAC Merger, Begins Trading on Nasdaq as XLAB

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Negative
Importance info
9
Price
$3.4
Mkt Cap
$97.109M
52W Low
$3.4
52W High
$7.39
52W Position info
0.0% above low
Off High info
54% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

XLAB is trading near its 52-week low of $3.4 (0.0% above the low) on light trading volume (0.1× avg).

Summary

Exascale Labs completed its SPAC merger with D. Boral ARC, becoming a public company with a $500M valuation. Massive redemptions left only 1.13M public shares, and the stock trades at $3.40 versus the $10.00 deal price.


Key Events · M&A and Partnerships · XLAB

  • Business Combination Closed

    Exascale Labs completed its merger with D. Boral ARC Acquisition I Corp. on August 27, 2026, with Exascale valued at $500 million based on $10.00 per share.

  • Massive SPAC Redemptions

    26,865,211 BCAR Class A shares were redeemed for cash, leaving only 1,134,789 public shares outstanding — a 96% redemption rate.

  • Dual-Class Voting Control

    Insiders hold 30,645,739 Class B Super Common Stock shares with 20 votes each, giving them 94.8% voting control despite owning less than half the economic interest.

  • Auditor Change

    HTL International, LLC appointed as independent auditor effective immediately; Guangdong Prouden CPAs GP dismissed. Guangdong Prouden's prior report contained a going concern qualification.


Analysis · XLAB · Technology

Exascale Labs Holdings Inc. completed its business combination with D. Boral ARC Acquisition I Corp. on August 27, 2026, transforming from a private AI infrastructure provider into a Nasdaq-listed public company. The deal valued Exascale at $500 million based on a $10.00 per share deemed value, with former Exascale securityholders receiving 50 million shares. Critically, 26.9 million BCAR public shares were redeemed for cash, leaving only 1.13 million public shares outstanding — a 96% redemption rate that signals weak SPAC investor conviction. The company now trades near its 52-week low of $3.40, far below the $10.00 deal valuation, suggesting the market is repricing the merger economics. The dual-class structure gives insiders 94.8% voting control through Class B Super Common Stock with 20 votes per share, while public Class A holders have minimal influence. The filing also discloses a going concern qualification in the predecessor's audited financials and the appointment of a new auditor, HTL International, LLC.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XLAB was trading at $3.40 on NASDAQ in the Technology sector, with a market capitalization of approximately $97.1M. The 52-week trading range was $3.40 to $7.39. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XLAB - Latest Insights